Drug Discovery and Development in Cancer and Cardiovascular Diseases

The  main aim of this review is to develop the evolving processes in cardiovascular and oncology drug discovery and development within a large pharmaceutical company. Importance is placed on the contrast between the academic and industrial research operating environments, which can influence the efficiency of research relationship between the two constituencies, but which plays such an important role in drug development.

 

    Related Conference of Drug Discovery and Development in Cancer and Cardiovascular Diseases

    June 16-17, 2025

    3rd Global Online Summit on Nanoscience and Nanotechnology

    Zurich, Switzerland
    June 23-24, 2025

    38th World Congress on Pharmacology

    Paris, France
    August 18-19, 2025

    40th World Congress on Pharmacology and Therapeutics

    Valencia, Spain
    September 19-20, 2025

    18th World Drug Delivery Summit

    Aix-en-Provence, France
    September 22-23, 2025

    Pharma Biotech Expo

    Toronto, Canada
    September 23-24, 2025

    10th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    November 13-14, 2025

    21st International Conference on Pharmaceutical Chemistry

    Aix-en-Provence, France
    November 20-21, 2025

    21st Annual Congress on Pharmacology and Toxicology

    Paris, France
    November 27-28, 2025

    4th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 27-28, 2025

    13th International Conference on Clinical Trials

    Amsterdam, Netherlands
    November 27-28, 2025

    4th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland

    Drug Discovery and Development in Cancer and Cardiovascular Diseases Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in